UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

Gene therapy, 2008-06, Vol.15 (12), p.911-920

2008

Volltextzugriff (PDF)

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Gene therapy, 2009-05, Vol.16 (5), p.689-699

2009

Volltextzugriff (PDF)

Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling

Gene therapy, 2012-05, Vol.19 (5), p.543-549

2012

Volltextzugriff (PDF)

Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors

Gene therapy, 2008-04, Vol.15 (8), p.604-616

2008

Volltextzugriff (PDF)

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy

Gene therapy, 2013-05, Vol.20 (5), p.521-528

2013

Volltextzugriff (PDF)

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer

Oral oncology, 2013-02, Vol.49 (2), p.108-118

2013

Volltextzugriff (PDF)

Phase I-II study of pegylated liposomal cisplatin (SPI-077 TM) in patients with inoperable head and neck cancer

Annals of oncology, 2001-04, Vol.12 (4), p.493-496

2001

Volltextzugriff (PDF)

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor

Gene therapy, 2010-08, Vol.17 (8), p.1000-1010

2010

Volltextzugriff (PDF)

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer

Gene therapy, 2016-04, Vol.23 (4), p.357-368

2016

Volltextzugriff (PDF)

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics

Cytokine & growth factor reviews, 2010-04, Vol.21 (2), p.91-98

2010

Volltextzugriff (PDF)

Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component

Cancer research (Chicago, Ill.), 1994-12, Vol.54 (23), p.6228-6234

1994

Volltextzugriff (PDF)

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling

Oncogene, 2014-03, Vol.33 (13), p.1700-1712

2014

Volltextzugriff (PDF)

Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood

Circulation research, 2003-11, Vol.93 (11), p.1023-1025

2003

Volltextzugriff (PDF)

Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression

International journal of cancer, 1997-04, Vol.71 (2), p.267-274

1997

Volltextzugriff (PDF)

Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells

Gene therapy, 2007-07, Vol.14 (13), p.998-1009

2007

Volltextzugriff (PDF)

Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck

European journal of cancer (1990), 2001-11, Vol.37 (16), p.2015-2022

2001

Volltextzugriff (PDF)

Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo

Gene therapy, 2008-03, Vol.15 (6), p.424-433

2008

Volltextzugriff (PDF)

Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery

Gene therapy, 2009-01, Vol.16 (1), p.78-92

2009

Volltextzugriff (PDF)

Heat shock proteins refine the danger theory

Immunology, 2000-03, Vol.99 (3), p.334-337

2000

Volltextzugriff (PDF)

Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA

Cancer research (Chicago, Ill.), 1993-09, Vol.53 (17), p.3860-3864

1993

Volltextzugriff (PDF)

A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy

Gene therapy, 2000-10, Vol.7 (19), p.1656-1663

2000

Volltextzugriff (PDF)

Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

Gene therapy, 1999-09, Vol.6 (9), p.1552-1557

1999

Volltextzugriff (PDF)

Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity

Gene therapy, 1998-02, Vol.5 (2), p.223-232

1998

Volltextzugriff (PDF)

Effective Targeting of Solid Tumors in Patients With Locally Advanced Cancers by Radiolabeled Pegylated Liposomes

Clinical cancer research, 2001-02, Vol.7 (2), p.243-254

2001

Volltextzugriff (PDF)

GENE THERAPY FOR PROSTATE CANCER: CURRENT STATUS AND FUTURE PROSPECTS

The Journal of urology, 2001-10, Vol.166 (4), p.1220-1233

2001

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(167)

Publikationsform

Sprache

Englisch
(198)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Life Sciences & Biomedicine
(147)
Humans
(111)
Animals
(93)
Biological And Medical Sciences
(83)
Mice
(66)
Medical Sciences
(64)
Gene Therapy
(56)
Oncology
(53)
Medicine, Research & Experimental
(46)
Research & Experimental Medicine
(46)
Tumors
(45)
Biotechnology & Applied Microbiology
(43)
Fundamental And Applied Biological Sciences. Psychology
(40)
Genetics & Heredity
(40)
Genetic Therapy - Methods
(38)
Biochemistry & Molecular Biology
(37)
Biotechnology
(34)
Health. Pharmaceutical Industry
(33)
Industrial Applications And Implications. Economical Aspects
(33)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling

Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer

Phase I-II study of pegylated liposomal cisplatin (SPI-077 TM) in patients with inoperable head and neck cancer

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor

Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer

Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics

Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling

Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood

Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression

Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells

Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck

Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo

Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery

Heat shock proteins refine the danger theory

Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA

A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy

Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity

Effective Targeting of Solid Tumors in Patients With Locally Advanced Cancers by Radiolabeled Pegylated Liposomes

GENE THERAPY FOR PROSTATE CANCER: CURRENT STATUS AND FUTURE PROSPECTS

Suchergebnisse filtern